Cargando…

Acceptability and efficacy of intra-rectal quinine alkaloids as a pre-transfer treatment of non-per os malaria in peripheral health care facilities in Mopti, Mali

BACKGROUND: The acceptability and efficacy of a new kit with a new formulation of quinine alkaloids designed for the intra-rectal administration in the treatment of non-per os malaria was assessed in the peripheral health care system of Mopti, Mali. METHODS: A single-arm trial was conducted from Aug...

Descripción completa

Detalles Bibliográficos
Autores principales: Thera, Mahamadou A, Keita, Falaye, Sissoko, Mahamadou S, Traoré, Oumar B, Coulibaly, Drissa, Sacko, Massambou, Lameyre, Valerie, Ducret, Jean Pascal, Doumbo, Ogobara
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1904225/
https://www.ncbi.nlm.nih.gov/pubmed/17519031
http://dx.doi.org/10.1186/1475-2875-6-68
_version_ 1782133974875766784
author Thera, Mahamadou A
Keita, Falaye
Sissoko, Mahamadou S
Traoré, Oumar B
Coulibaly, Drissa
Sacko, Massambou
Lameyre, Valerie
Ducret, Jean Pascal
Doumbo, Ogobara
author_facet Thera, Mahamadou A
Keita, Falaye
Sissoko, Mahamadou S
Traoré, Oumar B
Coulibaly, Drissa
Sacko, Massambou
Lameyre, Valerie
Ducret, Jean Pascal
Doumbo, Ogobara
author_sort Thera, Mahamadou A
collection PubMed
description BACKGROUND: The acceptability and efficacy of a new kit with a new formulation of quinine alkaloids designed for the intra-rectal administration in the treatment of non-per os malaria was assessed in the peripheral health care system of Mopti, Mali. METHODS: A single-arm trial was conducted from August 2003 to January 2004. An initial dose of diluted quinine alkaloids (20 mg/kg Quinimax(®)) was administered by the intra-rectal route to children with presumptive non per-os malaria at six peripheral heath care centres. The children were then referred to two referral hospitals where standard inpatient care including intravenous route were routinely provided. A malaria thick smear was done at inclusion and a second malaria thick smear after arrival at the referral facility, where a more complete clinical examination and laboratory testing was done to confirm diagnosis. Confirmed cases of severe malaria or others diseases were treated according to national treatment guidelines. Cases of non per-os malaria received a second dose of intra rectal quinine alkaloids. Primary outcome was acceptability of the intra rectal route by children and their parents as well as the ease to handle the kit by health care workers. RESULTS: The study included 134 children with a median age of 33 months and 53.7% were male. Most of the children (67%) and 92% of parents or guardians readily accepted the intra-rectal route; 84% of health care workers found the kit easy to use. At the peripheral health care centres, 32% of children had a coma score ≤ 3 and this was reduced to 10% at the referral hospital, following one dose of intra-rectal quinine alkaloids (IRQA). The mean time to availability of oral route treatment was 1.8 ± 1.1 days. Overall, 73% of cases were confirmed severe malaria and for those the case fatality rate was 7.2%. CONCLUSION: IRQA was well accepted by children, their parents/guardians and by the health workers at peripheral health facilities in Mopti, Mali. There was also a quick recovery from deep coma and a reduced case fatality rate in severe malaria.
format Text
id pubmed-1904225
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-19042252007-06-29 Acceptability and efficacy of intra-rectal quinine alkaloids as a pre-transfer treatment of non-per os malaria in peripheral health care facilities in Mopti, Mali Thera, Mahamadou A Keita, Falaye Sissoko, Mahamadou S Traoré, Oumar B Coulibaly, Drissa Sacko, Massambou Lameyre, Valerie Ducret, Jean Pascal Doumbo, Ogobara Malar J Research BACKGROUND: The acceptability and efficacy of a new kit with a new formulation of quinine alkaloids designed for the intra-rectal administration in the treatment of non-per os malaria was assessed in the peripheral health care system of Mopti, Mali. METHODS: A single-arm trial was conducted from August 2003 to January 2004. An initial dose of diluted quinine alkaloids (20 mg/kg Quinimax(®)) was administered by the intra-rectal route to children with presumptive non per-os malaria at six peripheral heath care centres. The children were then referred to two referral hospitals where standard inpatient care including intravenous route were routinely provided. A malaria thick smear was done at inclusion and a second malaria thick smear after arrival at the referral facility, where a more complete clinical examination and laboratory testing was done to confirm diagnosis. Confirmed cases of severe malaria or others diseases were treated according to national treatment guidelines. Cases of non per-os malaria received a second dose of intra rectal quinine alkaloids. Primary outcome was acceptability of the intra rectal route by children and their parents as well as the ease to handle the kit by health care workers. RESULTS: The study included 134 children with a median age of 33 months and 53.7% were male. Most of the children (67%) and 92% of parents or guardians readily accepted the intra-rectal route; 84% of health care workers found the kit easy to use. At the peripheral health care centres, 32% of children had a coma score ≤ 3 and this was reduced to 10% at the referral hospital, following one dose of intra-rectal quinine alkaloids (IRQA). The mean time to availability of oral route treatment was 1.8 ± 1.1 days. Overall, 73% of cases were confirmed severe malaria and for those the case fatality rate was 7.2%. CONCLUSION: IRQA was well accepted by children, their parents/guardians and by the health workers at peripheral health facilities in Mopti, Mali. There was also a quick recovery from deep coma and a reduced case fatality rate in severe malaria. BioMed Central 2007-05-22 /pmc/articles/PMC1904225/ /pubmed/17519031 http://dx.doi.org/10.1186/1475-2875-6-68 Text en Copyright © 2007 Thera et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Thera, Mahamadou A
Keita, Falaye
Sissoko, Mahamadou S
Traoré, Oumar B
Coulibaly, Drissa
Sacko, Massambou
Lameyre, Valerie
Ducret, Jean Pascal
Doumbo, Ogobara
Acceptability and efficacy of intra-rectal quinine alkaloids as a pre-transfer treatment of non-per os malaria in peripheral health care facilities in Mopti, Mali
title Acceptability and efficacy of intra-rectal quinine alkaloids as a pre-transfer treatment of non-per os malaria in peripheral health care facilities in Mopti, Mali
title_full Acceptability and efficacy of intra-rectal quinine alkaloids as a pre-transfer treatment of non-per os malaria in peripheral health care facilities in Mopti, Mali
title_fullStr Acceptability and efficacy of intra-rectal quinine alkaloids as a pre-transfer treatment of non-per os malaria in peripheral health care facilities in Mopti, Mali
title_full_unstemmed Acceptability and efficacy of intra-rectal quinine alkaloids as a pre-transfer treatment of non-per os malaria in peripheral health care facilities in Mopti, Mali
title_short Acceptability and efficacy of intra-rectal quinine alkaloids as a pre-transfer treatment of non-per os malaria in peripheral health care facilities in Mopti, Mali
title_sort acceptability and efficacy of intra-rectal quinine alkaloids as a pre-transfer treatment of non-per os malaria in peripheral health care facilities in mopti, mali
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1904225/
https://www.ncbi.nlm.nih.gov/pubmed/17519031
http://dx.doi.org/10.1186/1475-2875-6-68
work_keys_str_mv AT theramahamadoua acceptabilityandefficacyofintrarectalquininealkaloidsasapretransfertreatmentofnonperosmalariainperipheralhealthcarefacilitiesinmoptimali
AT keitafalaye acceptabilityandefficacyofintrarectalquininealkaloidsasapretransfertreatmentofnonperosmalariainperipheralhealthcarefacilitiesinmoptimali
AT sissokomahamadous acceptabilityandefficacyofintrarectalquininealkaloidsasapretransfertreatmentofnonperosmalariainperipheralhealthcarefacilitiesinmoptimali
AT traoreoumarb acceptabilityandefficacyofintrarectalquininealkaloidsasapretransfertreatmentofnonperosmalariainperipheralhealthcarefacilitiesinmoptimali
AT coulibalydrissa acceptabilityandefficacyofintrarectalquininealkaloidsasapretransfertreatmentofnonperosmalariainperipheralhealthcarefacilitiesinmoptimali
AT sackomassambou acceptabilityandefficacyofintrarectalquininealkaloidsasapretransfertreatmentofnonperosmalariainperipheralhealthcarefacilitiesinmoptimali
AT lameyrevalerie acceptabilityandefficacyofintrarectalquininealkaloidsasapretransfertreatmentofnonperosmalariainperipheralhealthcarefacilitiesinmoptimali
AT ducretjeanpascal acceptabilityandefficacyofintrarectalquininealkaloidsasapretransfertreatmentofnonperosmalariainperipheralhealthcarefacilitiesinmoptimali
AT doumboogobara acceptabilityandefficacyofintrarectalquininealkaloidsasapretransfertreatmentofnonperosmalariainperipheralhealthcarefacilitiesinmoptimali